Home > Target Markets

Cytogel has focused on developing products that will participate in markets with significant unmet needs. The market for pain management is such a market. It is a very large market, estimated to reach in excess of $75 billion worldwide by 2015, and very unsatisfied. It is estimated that 86 million Americans suffer chronic pain and almost half do not achieve adequate relief.

The markets for drug delivery technologies are many, based on the large number of drugs that could be incorporated into the hydrogels. Novel drug delivery systems, such as Cytogel's biodegradable polymers and hydrogels, can potentially be used to reformulate a number of existing drugs, improving their therapeutic product characteristics and may then extend their patent protection, thus extending their potential profitability to the manufacturer.